![](/img/cover-not-exists.png)
A Novel Reduced Toxicity Preparative Regimen For Hematopoietic Cell Allografting Combining Pentostatin (Nipent®) And Targeted Doses Of Intravenous Busulfan (Busulfex®) With Or Without Rituximab (PB ± R) Using CD4-Guided Immune Suppression: Preliminary Results Of An Ongoing Prospective Trial
M.A. Kharfan-Dabaja, J. Perkins, R. Cortes, L. Brand, H.F. Fernandez, J.L. Ochoa-Bayona, T. Field, L. Perez, C. McIsaac, B. Maddox, E. Ayala, R. Komrokji, J. Pinilla-Ibarz, E. Sotomayor, M. Tomblyn, CVolume:
16
Year:
2010
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2009.12.376
File:
PDF, 56 KB
english, 2010